​

InMed Pharmaceuticals Ownership | Who Owns InMed Pharmaceuticals?

OverviewRevenueFinancialsChart

InMed Pharmaceuticals Ownership Summary

InMed Pharmaceuticals is owned by 0.34% insiders, and 99.66% retail investors. AdvisorShares Pure Cannabis ETF is the top mutual fund, with 1.36% of its assets in InMed Pharmaceuticals shares.

INM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockInMed Pharmaceuticals-0.34%99.66%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.80%11.85%52.35%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-91.67%27-100.00%----100.00%--100.00%
Sep 30, 202411-8.33%1,113,450152.90%-0.86%775.00%1-66.67%
Jun 30, 202412-25.00%440,278-35.81%46.19%4-20.00%3-
Mar 31, 2024166.67%685,866-14.72%88.45%5-44.44%350.00%
Dec 31, 20231566.67%804,2502893.45%10837.71%950.00%2-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
AdvisorShares Pure Cannabis ETF16.43K1.36%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 04, 2026Vivo Opportunity, LLC-Buy$9.62K
Jun 03, 2026Vivo Opportunity, LLC-Buy$10.96K
Jun 08, 2026Vivo Opportunity, LLC-Buy$44.87K
Jun 05, 2026Vivo Opportunity, LLC-Buy$78.45K
Jun 02, 2026Vivo Opportunity, LLC-Buy$31.54K

Insider Transactions Trends

DateBuySell
2026 Q23-
2025 Q4--
2025 Q1--
2024 Q4--
2024 Q3-1

INM Ownership FAQ

Who Owns InMed Pharmaceuticals?

InMed Pharmaceuticals shareholders are primarily institutional investors at 0%, followed by 0.34% insiders and 0% retail investors. The average institutional ownership in InMed Pharmaceuticals's industry, Biotech Stocks , is 35.80%, which InMed Pharmaceuticals falls below.

Does Blackrock own InMed Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of InMed Pharmaceuticals.

Who is the top mutual fund holder of InMed Pharmaceuticals shares?

AdvisorShares Pure Cannabis ETF is the top mutual fund holder of InMed Pharmaceuticals shares, with 1.36% of its total shares outstanding invested in 16.43K InMed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools